Crohns Disease Treatment Market to Record a Robust Growth Rate of CAGR 3% During 2024

The Crohn’s & Colitis Foundation of America (CCFA) stated that over 1 Million Americans were diagnosed with Crohn's & ulcerative colitis disorders, with most of them aged above 30. Growing occurrence of Crohn's disease has triggered a robust demand for its therapeutics. A survey conducted by the US Center for Disease Control (CDC) has revealed that the incidence rate of Crohn's disease in the country is 3.1 to 14.6 new cases per 100,000 population annually.

The disease is highly prevalent in developed countries, especially in individuals who smoke. According to a study conducted by Persistence Market Research (PMR), demand for anti-inflammatory drugs and biologics for treating Crohn's disease will gain traction in the near future. PMR forecasts that the global market for Crohn's disease is set to reach US$ 4,474.8 Million by 2024-end, growing at a CAGR of 3% during the assessment period.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/9665

Company Profiles

  • Allergan, Inc.,
  • UCB S.A.
  • AbbVie Inc.
  • Perrigo Company plc
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • Ferring B.V.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/9665

Increasing demand for biologics for treating bowel disorders such as ulcerative collates and Crohn's disease is propelling the overall growth of Crohn's disease market. Moreover, drug manufacturers are actively focusing on advanced products having higher efficiency. The growing patient population is an additional factor expected to influence the market growth between 2016 and 2024.

Therefore, higher utilization and preference for biologics and anti-inflammatory drug therapies coupled with the surging popularity of biosimilars is expected to play an important role in shaping the market for the future.

Bottlenecks

The high cost of treatment will remain as a major impediment for the market. Further, the patient expiry of blockbuster drugs and lack of early diagnosis particularly in third world countries are some of the other hindrances that are likely to inhibit the market growth during the forecast period.

Major Trends

Higher preference for symptomatic therapeutic and drugs over surgeries, better treatment management of inflammatory bowel diseases, the arrival of enhanced drugs in the market owing to healthier investments in R&D programs are some of the key trends governing the market.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/9665

Market Overview

While biologics will continue to remain the most preferred drug type amongst both healthcare professionals and patients, the demand for anti-inflammatory drugs will also witness a rampant acceleration during the forecast period. Based on drug type, the anti-inflammatory drug segment is projected to reach a market valuation of US$ 1,095.9 Million by end of the assessment period.

Based on distribution channel, the hospital pharmacies will continue to be the leading segment of the market over the forecast period. Whereas, the retail pharmacies segment is projected to exhibit the highest growth, reaching a market valuation of US$ 1,470.2 Million by 2024.

PMR’s findings based on regional assessment suggest that the Crohn's disease market in North America will continue to lead the pack during the forecast period. The region’s market is expected to value US$ 3,149.8 Million over 2014. However, Asia-Pacific is expected to witness the highest CAGR over the forecast period. The APAC market is projected to create an absolute $ opportunity of US$ 13.2 Million in 2017 over 2016.

Report To Be Covered

  • Sales Revenue: Market Share, Growth Rate, Current Market Analysis.
  • Product Revenue for Top Players: Market Share, Growth Rate, Current Market Situation Analysis.
  • Industry Trends: United States and Other Regions Revenue, Status and Outlook.
  • Market Segment: By Types, By Applications, By Regions/ Geography.
  • Market Environment: Government Policies, Technological Changes, Market Risks.
  • Market Drivers: Growing Demand, Reduction in Cost, Market Opportunities and Challenges.
  • Competitive Landscape: By Manufacturers, Development Trends, Marketing Area

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

  • Feminine Hygiene Product Market – Feminine Hygiene Products Market Segmented By Sanitary Pads/Napkins, Tampons, Panty Liners, Menstrual Cups, and Feminine Hygiene Wash. For More Information
  • Elder Care Services Market – Elder Care Services Market Segmented By Home-based Care, Community-based Care, Institutional Care Services and Financing Source By Public Expenditure, Private Source, Out-of-Pocket Spending. For More Information

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish Kolte
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Salessales@persistencemarketresearch.com
Websitehttps://www.persistencemarketresearch.com